MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$5,857,024
Prepaid expenses and
other current assets
$890,149
(43.81%↑ Y/Y)
Inventories
$369,974
Total current assets
$7,117,147
(262.10%↑ Y/Y)
Total assets
$7,117,147
(262.10%↑ Y/Y)
Total liabilities and
stockholders equity...
$7,117,147
(262.10%↑ Y/Y)
Total stockholders
equity (deficit)
$3,868,463
(148.64%↑ Y/Y)
Total liabilities
$3,248,684
(-67.25%↓ Y/Y)
Accumulated deficit
-$30,480,973
(-62.84%↓ Y/Y)
Additional paid-in capital
$34,349,418
(219.20%↑ Y/Y)
Total current
liabilities
$3,152,432
(-68.06%↓ Y/Y)
Forward purchase
agreement liability
$96,252
(95.23%↑ Y/Y)
Common stock 0.0001 par
value 490,000,000...
$17
(-99.65%↓ Y/Y)
Series a convertible
preferred stock, 25,000...
$1
Promissory note fee related
party-Related Party
$1,000,000
(0.00%↑ Y/Y)
Accounts payable
$857,925
(-40.09%↓ Y/Y)
Loan and transfer
notes payable related...
$499,214
Accrued expenses
$441,614
(38.41%↑ Y/Y)
Due to
affiliate-Affiliates
$353,679
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc. (ASBP)